Literature DB >> 6883199

The effect of alloxan- and streptozotocin-induced diabetes on calcium transport in rat cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitines.

G D Lopaschuk, S Katz, J H McNeill.   

Abstract

Isolated working hearts from diabetic rats have a decreased ability to respond to increasing preload or afterload. The ability of cardiac sarcoplasmic reticulum to transport Ca2+ was examined in diabetic rats. Hearts were obtained from female Wistar rats 120 days or 7 days after the induction of diabetes by a single I.V. injection of either alloxan (65 mg/kg) or streptozotocin (60 mg/kg). At all Ca2+ concentrations tested (0.2-5.0 microM free Ca2+) cardiac sarcoplasmic reticulum from 120-day diabetic rats showed a significant decrease in the rate of ATP-dependent tris-oxalate facilitated Ca2+ transport (62-73% of control). This was accompanied by a decrease in Ca2+ ATPase activity. The levels of long chain acylcarnitines associated with the microsomal sarcoplasmic reticulum preparation from 120-day diabetic rats were significantly higher than those present in sarcoplasmic reticulum from control rats. Palmitylcarnitine, the most abundant of the long chain acylcarnitines, in concentrations less than 7 microM was found to be a potent time-dependent inhibitor of Ca2+ transport in both control and diabetic rat sarcoplasmic reticulum preparations; inhibition of Ca2+ transport was found to be more marked in the control preparations. This would indicate that a degree of inhibition produced by the high endogenous levels of palmitylcarnitine may already be present in the diabetic rat preparations. Cardiac sarcoplasmic reticulum prepared from acutely diabetic rats (7 days) did not show any decrease in Ca2+ transport ability. Levels of long chain acylcarnitines associated with the microsomal preparation enriched in sarcoplasmic reticulum were also unchanged. These findings suggest that the alteration in heart function in 120-day diabetic rats may be due to the buildup of cellular long chain acylcarnitines which inhibit sarcoplasmic reticulum Ca2+ transport. The absence of any change in Ca2+-transport activity or levels of long chain acylcarnitines at 7 days suggests that the alterations seen in 120-day diabetic rats must be of gradual onset.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883199     DOI: 10.1139/y83-068

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  20 in total

Review 1.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

3.  Cardiac pathology in the hypertensive diabetic rat. Biventricular damage with right ventricular predominance.

Authors:  F S Fein; S Cho; B E Zola; B Miller; S M Factor
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Decreased sensitivity of contraction to changes of intracellular pH in papillary muscle from diabetic rat hearts.

Authors:  D Lagadic-Gossmann; D Feuvray
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

5.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

6.  Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1990-06       Impact factor: 1.880

7.  The metabolic effect of carbon monoxide on the heart.

Authors:  H Hattori; N Sugawara; K Nakamura; J Furuno
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

Review 8.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.

Authors:  S L Lee; I Ostadalova; F Kolar; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

10.  Effects of some L-carnitine derivatives on heart membrane ATPases.

Authors:  N S Dhalla; F Kolár; K R Shah; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.